GBI Bio

📢 Quickly approaching, GBI Bio will be attending the Festival of Biologics Conference in San Diego from April 23rd - 24th! As one of the only Contract Development and Manufacturing Organization (CDMO)’s with Drug Substance and Drug product services at one location, we specialize in helping biopharma partners advance their biologics from concept to clinic and commercial. If you're attending the conference and looking to: ✅ Accelerate your development timelines ✅ Navigate complex tech transfers ✅ Scale up manufacturing with confidence Let’s connect! Our team member will be onsite and would love to explore how we can support your program's success. Message us to schedule a meeting during the conference via the link below: 🔗 https://lnkd.in/gRexfGHw Looking forward to insightful conversations and new collaborations! #FestivalOfBiologics #BiologicsDevelopment #CDMO #Biotech #Pharma #PartnerWithUs

Florida-based CDMO, GBI Biomanufacturing (GBI), has announced the appointment of Sven Lee to its board of directors. Mr. Lee brings decades of global experience in the biologics CDMO sector, having held executive and board positions at companies such as Abzena, Catalent, and Biocina, with expertise encompassing strategic growth, marketing, commercialization, licensing, and innovation in drug development.  GBI's Chairman and CEO, Karl Pinto, expressed enthusiasm about the addition, highlighting Mr. Lee's industry knowledge and reputation as assets that will enhance GBI's commitment to delivering high-quality development and manufacturing solutions to clients worldwide. Mr. Lee reciprocated, expressing his honor to join GBI during a period of significant investments and capacity expansion, aligning with his passion for advancing complex biopharmaceutical solutions. Read more here👇

🌟 Exciting News from the Next-Gen Summit in Boston! 🌟 GBI Bio team members Nicholas Filipancic, MBA & Muctarr Sesay are at the Noval Conjugates Summit in Boston, connecting with industry leaders, innovators, and partners in the conjugation space. Don't miss Muctarr Sesay as he takes the stage at 4:15 PM EST to discuss "Strategies for Process Development and "GMP"-nization of Bio-Conjugates: Aspects of Antibody Oligonucleotide Conjugation (AOC)", bringing fresh insights into the future of bioconjugates. If you're attending, be sure to stop by and say hello! 👋 Let’s talk about how we can drive innovation together. #NextGenSummit #ContractManufacturing #Innovation #Boston

👀 💭 New Blog: Three Predictions for the 4th Annual Novel Conjugate Summit in Boston 🔬 As the biopharma world gears up for this premier event, our Senior Director of Business development, Nicholas Filipancic, MBA shares key insights into the trends shaping the future of novel conjugates. From innovative payload-linker strategies to the latest in manufacturing scalability, here’s what we expect to see at this year’s summit 👇 🔗 Read our full blog here: https://lnkd.in/eQchrzb6 #Biopharma #NovelConjugates #CDMO #ManufacturingInnovation #BostonSummit

In the world of biomanufacturing, the real pot of gold isn’t at the end of the rainbow—it’s in the breakthroughs we achieve together! Wishing you a St. Patrick’s Day full of success, discovery, and a little bit of luck! 🌈 #CDMO #Biotech #St.Patrick'sDay

Exciting News! 📢   We are thrilled to welcome Sven Lee to GBI Bio's Board of Directors! With his extensive global experience in the biologics CDMO space, Sven brings valuable expertise that will help us reach more clients and their cutting-edge products to help drive innovation & excellence and bring them to market efficiently.   At GBI we are committed to serve and deliver high-quality contract development and manufacturing solutions encompassing drug substance and drug product to our clients worldwide, and having strong leadership is key to our success. We look forward to the impact Sven will make as we continue to grow and evolve in this dynamic industry.   Read more about this exciting announcement in our official press release via the link below 👇 🔗 https://lnkd.in/ee97Vk4x Please join us in giving a warm welcome to Sven Lee! 👏   #Leadership #BoardOfDirectors #Welcome #Innovation #Manufacturing

🔬 CDMO Expert Insights – Biologics Tech Transfer! ⏳🎥 Tech transfer is a critical step in bringing biologics from development to manufacturing—complex, time-sensitive, and requiring deep expertise. Our new Subject Matter Expert (SME) series, segment 1, consist of a 2-minute knowledge drop from our Manager of MSAT-USP Natalia Bourguignon, Ph.D. Stay tuned for actionable insights on navigating your biologics program with confidence. Click the link to watch the short clip-on Tech Transfer insights: 🔗 https://lnkd.in/etX_qaca #Biologics #TechTransfer #CDMO #ExpertInsights #Biopharma #Biomanufacturing

Happy International Women’s Day to the incredible women of GBI Bio! Your hard work, passion, and strength make a difference every day. We celebrate you today and always! #Internationalwomensday #biotech #women #CDMO

🚀 New Blog Alert! 🚀 In the fast-paced world of biopharmaceutical production, efficiency is everything. From early development to large-scale manufacturing, partnering with the right Cell Line CDMO can make all the difference. John Neville, Ph.D.'s latest blog titled, "Maximizing Efficiency in Biopharmaceutical Production Through Cell Line CDMO Partnerships," explores how GBI Bio's strategic collaborations with CLD partners can benefit your program: ✅ Tailored CLD for Unique Drug Substances ✅ Flexibility and Risk Mitigation in the Bioprocessing Pipeline ✅ Access to Cutting-Edge Technologies and Expertise If you're looking to streamline your biopharma operations, this is a must-read! 🔬💡 📖 Read the full blog here: https://lnkd.in/eG3cbFCm #Biopharma #CDMO #CellLineDevelopmentPartnerships #Biomanufacturing #Efficiency

GBI Bio is heading to the 4th Annual Novel Conjugates Summit! 🏙️✨ As a leading Contract Development Manufacturing Organization (CDMO) specializing in large molecules (antibodies, recombinant proteins, etc.) & bioconjugation, we are excited to connect with industry leaders, scientists, and innovators shaping the future of conjugate therapeutics. Let’s discuss how our cutting-edge capabilities, robust quality systems, and scalable manufacturing solutions can help accelerate your next breakthrough. 📅 Date: March 25th-27th 📍 Location: Boston, MA GBI Attending Members: 🙋♂️ Muctarr Sesay 🙋♂️ Nicholas Filipancic, MBA Are you attending? Let’s set up a time to chat! Send us a message via the link below👇 🔗 https://lnkd.in/gRexfGHw #NovelConjugatesSummit #Bioconjugation #CDMO #Biotech #Pharma #Boston